PAHC Phibro Animal Health Corp
Price (delayed)
$23.64
Market cap
$957.51M
P/E Ratio
49.25
Dividend/share
$0.48
EPS
$0.48
Enterprise value
$1.64B
Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce
Highlights
PAHC's net income is up by 31% year-on-year and by 11% since the previous quarter
PAHC's EPS is up by 30% year-on-year and by 12% since the previous quarter
PAHC's P/E is 53% below its last 4 quarters average of 103.7 but 34% above its 5-year quarterly average of 36.8
PAHC's debt has soared by 59% QoQ and by 59% YoY
The quick ratio has decreased by 22% from the previous quarter and by 15% YoY
Key stats
What are the main financial stats of PAHC
Market
Valuations
Earnings
Shares outstanding
40.5M
Market cap
$957.51M
Enterprise value
$1.64B
Price to earnings (P/E)
49.25
Price to book (P/B)
3.88
Price to sales (P/S)
0.87
EV/EBIT
27.51
EV/EBITDA
16.65
EV/Sales
1.49
Revenue
$1.11B
Gross profit
$352.12M
Operating income
$81.57M
Net income
$19.32M
EBIT
$59.74M
EBITDA
$98.71M
Free cash flow
$15.33M
Per share
Balance sheet
Liquidity
EPS
$0.48
EPS diluted
$0.48
Free cash flow per share
$0.38
Book value per share
$6.09
Revenue per share
$27.31
TBVPS
$29.41
Total assets
$1.29B
Total liabilities
$1.04B
Debt
$753.13M
Equity
$246.8M
Working capital
$512.9M
Debt to equity
3.05
Current ratio
3.2
Quick ratio
1.11
Net debt/EBITDA
6.95
Margins
Efficiency
Dividend
EBITDA margin
8.9%
Gross margin
31.8%
Net margin
1.7%
Operating margin
7.4%
Return on assets
1.8%
Return on equity
7.5%
Return on invested capital
4.8%
Return on capital employed
5.7%
Return on sales
5.4%
Dividend yield
2.03%
DPS
$0.48
Payout ratio
100%
PAHC stock price
How has the Phibro Animal Health stock price performed over time
Intraday
1.42%
1 week
3.96%
1 month
-0.21%
1 year
83.11%
YTD
12.57%
QTD
12.57%
Financial performance
How have Phibro Animal Health's revenue and profit performed over time
Revenue
$1.11B
Gross profit
$352.12M
Operating income
$81.57M
Net income
$19.32M
Gross margin
31.8%
Net margin
1.7%
PAHC's operating income is up by 42% year-on-year and by 14% since the previous quarter
PAHC's net income is up by 31% year-on-year and by 11% since the previous quarter
The operating margin rose by 28% year-on-year and by 7% since the previous quarter
PAHC's gross profit is up by 18% year-on-year and by 7% since the previous quarter
Growth
What is Phibro Animal Health's growth rate over time
Valuation
What is Phibro Animal Health stock price valuation
P/E
49.25
P/B
3.88
P/S
0.87
EV/EBIT
27.51
EV/EBITDA
16.65
EV/Sales
1.49
PAHC's P/E is 53% below its last 4 quarters average of 103.7 but 34% above its 5-year quarterly average of 36.8
PAHC's EPS is up by 30% year-on-year and by 12% since the previous quarter
PAHC's P/B is 34% above its last 4 quarters average of 2.9 and 21% above its 5-year quarterly average of 3.2
The equity is down by 9% year-on-year and by 4.5% since the previous quarter
The stock's price to sales (P/S) is 24% more than its last 4 quarters average of 0.7 and 9% more than its 5-year quarterly average of 0.8
The revenue has increased by 13% year-on-year and by 6% since the previous quarter
Efficiency
How efficient is Phibro Animal Health business performance
The return on equity is up by 39% year-on-year and by 14% since the previous quarter
Phibro Animal Health's ROA has increased by 20% YoY
The ROIC has increased by 17% YoY but it has decreased by 2% from the previous quarter
PAHC's return on sales is up by 15% year-on-year and by 3.8% since the previous quarter
Dividends
What is PAHC's dividend history
DPS
$0.48
Dividend yield
2.03%
Payout ratio
100%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Phibro Animal Health financials performed over time
Phibro Animal Health's total assets is 24% higher than its total liabilities
The total liabilities rose by 48% year-on-year and by 47% since the previous quarter
Phibro Animal Health's total assets has increased by 33% QoQ and by 32% YoY
PAHC's debt to equity has soared by 74% YoY and by 67% from the previous quarter
PAHC's debt has soared by 59% QoQ and by 59% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.